Bioton S.A.
Develops and manufactures recombinant human insulin for global diabetes care solutions.
BIO | WAR
Overview
Corporate Details
- ISIN(s):
- PLBIOTN00029
- LEI:
- 259400I5R1L3OPCGII81
- Country:
- Poland
- Address:
- Warszawa Starościńska 5, 02-516 Warszawa
- Website:
- https://bioton.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Bioton S.A. is an innovative biotechnology company specializing in providing comprehensive solutions for diabetes care. The company's core activities include the research, development, manufacturing, and commercialization of pharmaceutical products, with a primary focus on recombinant human insulin. Bioton manages the entire drug production process, from advanced R&D and the synthesis of active pharmaceutical ingredients to the distribution of finished medicinal products. Recognized as a leader in the Polish market, the company is also one of the top commercial manufacturers of recombinant human insulin globally, operating from its modern production facility near Warsaw.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 19:17 |
Earnings Release
Bioton S.A. Wybrane dane w EUR Jednostkowe_1H 2025
|
Polish | 441.3 KB | ||
| 2025-09-17 19:17 |
Earnings Release
Bioton S.A. Wybrane dane w EUR Jednostkowe_1H 2025
|
Polish | 442.7 KB | ||
| 2025-09-17 19:17 |
Audit Report / Information
Raport z przeglądu śródrocznego skróconego SSF_MSSF skonsolidowane
|
Polish | 235.8 KB | ||
| 2025-09-17 19:17 |
Audit Report / Information
Raport z przeglądu śródrocznego skróconego JSF_MSSF jednostkowe
|
Polish | 233.3 KB | ||
| 2025-09-17 19:17 |
Management Discussion and Analysis
Sprawozdanie_Zarzadu_1H 2025
|
Polish | 1.7 MB | ||
| 2025-09-17 19:17 |
Interim Report
Sprawozdanie finansowe_ŚSSF_1H 2025 skonsolidowane
|
Polish | 1.1 MB | ||
| 2025-09-17 19:17 |
Interim Report
Sprawozdanie finansowe_ŚJSF_1H 2025 jednostkowe
|
Polish | 1.2 MB | ||
| 2025-08-20 15:55 |
Report Publication Announcement
Zmiana terminu publikacji skonsolidowanego "rozszerzonego" raportu półrocznego …
|
Polish | 774 bytes | ||
| 2025-07-29 17:13 |
Board/Management Information
Romuald Harwas życiorys
|
English | 150.3 KB | ||
| 2025-07-29 17:13 |
Board/Management Information
Powołanie Członka Zarządu - Content (PL)
|
Polish | 1.1 KB | ||
| 2025-07-29 17:04 |
Board/Management Information
Rezygnacja Członka Zarządu - Content (PL)
|
Polish | 346 bytes | ||
| 2025-07-25 15:29 |
Major Shareholding Notification
Otrzymanie zawiadomienia na podstawie art. 69 Ustawy o ofercie publicznej i war…
|
Polish | 2.5 KB | ||
| 2025-06-24 12:04 |
Registration Form
Xia Kaiguo CV
|
English | 131.3 KB | ||
| 2025-06-24 12:04 |
Post-Annual General Meeting Information
Powołanie osoby nadzorującej BIOTON S.A. - Content (PL)
|
Polish | 1.2 KB | ||
| 2025-06-23 14:50 |
Post-Annual General Meeting Information
Uchwały ZWZ z dnia 23.06.2025
|
Polish | 258.4 KB |
Automate Your Workflow. Get a real-time feed of all Bioton S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Bioton S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Bioton S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
